Quanta Announces Significant Advancements in ATP Production with Polarization Technology Platform

BURBANK, Calif., May 13, 2020 /PRNewswire/ -- Quanta, Inc. QNTA, an applied sciences company focused on increasing the potency and efficiency of plant matter, today announced the results of a new study that measured the impact of polarized Vitamin C, Vitamin A, and Alginic Acid in ATP (adenosine triphosphate) production. The results of the study indicated significant increases in ATP* production for all three materials tested, and mark a milestone for Quanta, as the foundation for new offerings into larger, global markets for skincare and anti-aging products. (The full company abstract is available HERE)

ATP production level in primary human fibroblast cells was measured to validate the effectiveness of polarization in cellular functions for cosmetic use.

Summary of Results

• Vitamin A (Retinol) – 282% Increase in ATP production. Retinol naturally restores aged skin, enables continued production of healthy skin cells, smoothing of wrinkles, and protection against infection.
  
  
• Vitamin C - 215% Increase in ATP production. Vitamin C naturally promotes collagen production, protects and repairs skin cells from damaging free radicals caused by UV exposure and is an essential element of youthful skin.
  
  
• Alginic Acid - 144% Increase in ATP production. Alginic Acid helps lock moisture in the skin for deep hydration.
  
  
• Vitamin A (Retinol), Vitamin C and Alginic Acid represent key elements in the skin care industry and have a combined global market of more than $10B.

"The data from these trials validates and demonstrates the strength of our technology platform, and will help us bring new, exciting and effective products to the skin care market," said Eric Rice, CEO of Quanta. "We are currently running additional trials and tests, and we have good reason to believe that these numbers will prove to be conservative in terms of efficacy of our process on these ingredients, where there is potential for even further optimization."

"This is an exciting time for Quanta. It represents a milestone for us as we move beyond cannabis, and proliferate to other organic formulas, products and licensing. We could not be more excited about the discoveries we have made to date and are optimistic about what we will be able to do in the future."

"We anticipate launching our own branded products in the skincare/anti-aging category by the end of this year, and ultimately co-branding with other healthcare and nutraceutical leaders who want the best, most effective products in the category for their customers," concluded Mr. Rice.

*ATP, adenosine triphosphate is a nucleotide that has been known to drive and participate in countless intracellular processes. It is effective in providing anti-aging protection, as well as skin-moisturizing and soothing properties. Additionally, as a major energy molecule for all intracellular processes, ATP also plays a major role in skin rejuvenation.

About Quanta: 
Quanta, Inc. ("Quanta") is a cutting-edge technology platform whose patented, proprietary technology harnesses advances in quantum biology to increase the potency of active ingredients. Currently, Quanta supports product formulations in pain management, anti-inflammation, skincare, anti-aging, nutritional supplements, and plant-based consumables. Ultimately, Quanta's mission is to deliver better, more effective ingredients to elevate product efficacy, reduce waste and facilitate healthier, more sustainable consumption.

The established resonance theory behind Quanta's polarization process has many potential applications. From potentiating bio-ingredients to produce more-effective carbon-trapping plants to transformative anti-aging solutions Quanta's technology has the opportunity to upend how commercial products are made and the benefits from them. Already we see multi-trillion-dollar global industries benefiting from Quanta's technology. You can find more about Quanta at https://buyquanta.com/.

Contacts:
Darrow Associates, Inc.
Peter Seltzberg, Managing Director, IR
pseltzberg@darrowir.com
(516) 419-9915

SOURCE Quanta, Inc.